SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma’s arm gets EIR from USFDA for New York facility

30 Jun 2025 Evaluate

Marksans Pharma’s subsidiary -- Time-Cap Laboratories Inc has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its manufacturing facility located at Michael Avenue, Farmingdale, New York, USA. Current Good Manufacturing Practices (cGMP) inspection was conducted by the USFDA from April 16, 2025 to April 24, 2025. 

Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.

Marksans Pharma Share Price

178.75 -1.75 (-0.97%)
17-Apr-2026 12:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.00
Dr. Reddys Lab 1227.00
Cipla 1238.90
Zydus Lifesciences 943.65
Lupin 2310.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×